UNIVERSITY of Newcastle researcher Dr Aleona Swegen, a member of the Hunter Medical Research Institute’s Infertility and Reproduction Research Program, is driving a breakthrough in fertility treatment. Dr Sewgan has secured $200,000 from the inaugural Newcastle Permanent Innovation Accelerator Program for her technology, SpermSafe. Dr Swegen created SpermSafe as a storage medium that improves survival […]
Newcastle Permanent’s Paul Juergens, Honeysuckle Health CEO and Dr Swegen’s Program Coach Rhod McKensey, Dr Aleona Swegen, HMRI CEO and Institute Director Professor Frances Kay. Photo: supplied.
